Lanean...

Considerations in the development of generic disease therapies for multiple sclerosis

PURPOSE OF REVIEW: Medication prices are a major contributor to the high cost of care for multiple sclerosis (MS). The patents for some of the initial injectable therapies for relapsing MS recently expired, permitting development, regulatory approval, and marketing of generic alternatives with the p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurol Clin Pract
Egile Nagusiak: Hua, Le H., Cohen, Jeffrey A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2016
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4987120/
https://ncbi.nlm.nih.gov/pubmed/27574572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000267
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!